Lloyd J Edwards (Lloyd Edwards)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Chronic Obstructive Pulmonary Disease

Pseudomonas Aeruginosa

Cell Proliferation

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

American journal of physiology. Lung cellular and molecular physiology

This page only lists publications with an associated author ORCID identifier.

Publications

Scott R Plotkin, Jeffrey Allen, Girish Dhall, Jian L Campian, D Wade Clapp, Michael J Fisher, Rakesh K Jain, James Tonsgard, Nicole J Ullrich, Coretta Thomas, Lloyd J Edwards, Bruce R Korf, Roger J Packer, Matthias A Karajannis, Jaishri O Blakely
Multicenter, prospective, phase 2 study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma. Neuro-oncology (2023)
Annika Åstrand, Emily Falk Libby, Ren-Jay Shei, Jacelyn E Peabody Lever, Niroop Kaza, Adegboyega Timothy Adewale, Evan Boitet, Lloyd J Edwards, Martin Hemmerling, James Root, Botilda Lindberg, Cecilia Wingren, Anna Malmgren, Juan Sabater, Steven M Rowe
Preclinical evaluation of the epithelial sodium channel inhibitor AZD5634 and implications on human translation. American journal of physiology. Lung cellular and molecular physiology 323 (5) (2022)
Brian D Weiss, Pamela L Wolters, Scott R Plotkin, Brigitte C Widemann, James H Tonsgard, Jaishri O Blakely, Jeffrey C Allen, Elizabeth K Schorry, Bruce R Korf, Nathan J Robison, Stewart Goldman, Alexander A Vinks, Chie Emoto, Tsuyoshi Fukuda, Coretta T Robinson, Gary R Cutter, Lloyd J Edwards, Eva Dombi, Nancy Ratner, Roger Packer, Michael J Fisher
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2021)